Alzheimer's Disease (AD) is a neurological disease that is the most common cause of dementia. The connections between the brain cells degenerate and eventually die due to a generation of plaques and tangles in and between the cells, particularly in the hippocampus and frontal cortex. The disease leads to memory loss, and in the later stages, an inability to perform daily activities. Alzheimer's is a progressive disease, and the symptoms of the patient worsen over time as the brain is more widely affected. It is the sixth leading cause of death in the United States. There is currently no cure for Alzheimer's, but there exist treatments for symptoms as well as a multitude of ongoing research projects.
Alzheimer's Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Alzheimer's Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 2415 products for the study of Alzheimer's Disease that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence from our catalog of antibodies and ELISA kits.
Alzheimer's Disease is also known as Alzheimer Dementia, Alzheimer Disease, Alzheimer Type Dementia, Alzheimer Type Senile Dementia, Alzheimer's Dementia.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.